Background Image
Previous Page  135 / 156 Next Page
Show Menu
Previous Page 135 / 156 Next Page
Page Background





Griffiths JD, Middle JV, Barron FA, Grant SJ, Popham PA, Royse CF. Transversus abdominis

plane block does not provide additional benefit to multimodal analgesia in gynecological

cancer surgery. Anesth Analg 2010; 111(3): 797-801.


Grover VK, Mathew PJ, Yaddanapudi S, Sehgal S. A single dose of preoperative gabapen-

tin for pain reduction and requirement of morphine after total mastectomy and axillary

dissection: randomized placebo-controlled double-blind trial. J Postgrad Med 2009;

55(4): 257-260.


Hagen NA, du Souich P, Lapointe B, Ong-Lam M, Dubuc B, Walde D, Love R, Ngoc

AH;Canadian Tetrodotoxin Study Group. Tetrodotoxin for moderate to severe cancer

pain: a randomized, double blind, parallel design multicenter study. J Pain Symptom

Manage 2008; 35(4): 420-429.


Hagen NA, Fisher K, Victorino C, Farrar JT. A titration strategy is needed to manage break-

through cancer pain effectively: observations from data pooled from three clinical trials. J

Palliat Med 2007; 10(1): 47-55.


Hagen NA, Moulin DE, Brasher PM, Biondo PD, Eliasziw M, Watanabe SM, Stiles CR. A

formal feasibility study of sublingual methadone for breakthrough cancer pain. Palliat

Med 2010; 24(7): 696-706.


Hald K, Klow NE, Qvigstad E, Istre O. Laparoscopic occlusion compared with embolization

of uterine vessels: a randomized controlled trial. Obstet Gynecol 2007; 109(1): 20-27.


Hanaoka K, Yoshimura T, Tomioka T, Sakata H. [Clinical study of one-day fentanyl patch in

patients with cancer pain--evaluation of the efficacy and safety in relation to treatment

switch from opioid analgesic therapy]. Masui 2011; 60(2): 147-156.


Hashiguchi S, Morisaki H, Kotake Y, Takeda J. Effects of morphine and its metabolites on

immune function in advanced cancer patients. J Clin Anesth 2005; 17(8): 575-580.


Hashizume T, Tomiyasu S, Yomiya K, Yoshimoto T, Harada A, Matoba M. [Validity of

recommended minimum dose of prior morphine to initiate transdermal fentanyl patch in

prescribing information - multicenter survey of on prescriptions by palliative care specia-

lists in Japan]. Gan To Kagaku Ryoho 2007; 34(6): 897-902.


Haslbauer F, Fiegl M. Bisphosphonates as adjuvant therapy in multimodal pain manage-

ment. Memo – Magazine of European Medical Oncology 2009; 2 (3), 161 – 165.


Hawley P, Beddard-Huber E, Grose C, McDonald W, Lobb D, Malysh L. Intrathecal infu-

sions for intractable cancer pain: a qualitative study of the impact on a case series of

patients and caregivers. Pain Res Manag 2009; 14(5): 371-379.


He BM, Li WS, Li WY. [Effect of previous analgesia of scalp acupuncture on post-operative

epidural morphine analgesia in the patient of intestinal cancer]. Zhongguo Zhen Jiu 2007;

27(5): 369-371.


Heiskanen T, Matzke S, Haakana S, Gergov M, Vuori E, Kalso E. Transdermal fentanyl in

cachectic cancer patients. Pain 2009; 144(1-2): 218-222.


Heller L, Kowalski AM, Wei C, Butler CE. Prospective, randomized, double-blind trial of

local anesthetic infusion and intravenous narcotic patient-controlled anesthesia pump for

pain management after free TRAM flap breast reconstruction. Plast Reconstr Surg 2008;

122(4): 1010-1018.